Ravindran Kanesvaran, Chairman of the Division of Medical Oncology at the National Cancer Centre Singapore, and
Distinguished Professor of Geriatric Oncology at Duke-NUS Medical School, shared a post on LinkedIn:
“Yesterday, we were delighted to host the Johnson and Johnson APAC team at Singapore General Hospital Division of Pathology and the National Cancer Centre Singapore.
Their visit (led by Matthias Skillecorn), Dianne Baunbaek, and their precision oncology team included engaging discussions and lab tours with SGH Pathology and NCCS teams, focusing on precision medicine and molecular diagnostics. The team’s curiosity and insight underscored the importance of public-private collaboration in advancing healthcare innovation.
By bridging research and clinical practice, deepening understanding of molecular testing, and supporting targeted therapy workflows, such exchanges drive better outcomes for patients. Shared learning across sectors keeps us at the forefront of personalized care.”
More posts featuring Ravindran Kanesvaran.
